P-Selectin Blockers [MoA] class drugs

1 result
  • adakveo - crizanlizumab injection

    (Crizanlizumab)
    Novartis Pharmaceuticals Corporation
    Adakveo reduces the frequency of vaso-occlusive crises (VOCs) in adults and pediatric patients aged 16 and older with sickle cell disease.